Your browser doesn't support javascript.
loading
An induced pluripotent stem cell line (CIMRi001-A) from a Vici syndrome donor with a homozygous recessive c.1007A>G (p.Q336R) mutation in the EPG5 gene.
Mitchell, Matthew W; Grandizio, Christine; Turan, Nahid; Requesens, Deborah V.
Afiliação
  • Mitchell MW; Coriell Institute for Medical Research, Camden, NJ 08103, USA. Electronic address: mmitchell@coriell.org.
  • Grandizio C; Coriell Institute for Medical Research, Camden, NJ 08103, USA.
  • Turan N; Coriell Institute for Medical Research, Camden, NJ 08103, USA.
  • Requesens DV; Coriell Institute for Medical Research, Camden, NJ 08103, USA; The Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Stem Cell Res ; 63: 102833, 2022 08.
Article em En | MEDLINE | ID: mdl-35700637
Vici syndrome is a rare, congenital disorder that affects multiple systems and is caused by mutations in the EPG5 gene that encodes for ectopic P-granules autophagy protein 5 (EPG5). The induced pluripotent stem cell (iPSC) line described here was generated from a dermal fibroblast cell line from an 8-year-old male donor with a homozygous recessive c.1007A>G (p.Q336R) mutation in the EPG5 gene. This iPSC model of Vici syndrome provides a unique and valuable resource for investigators to study the pathology of EPG5 mutations and the aetiology of the disease as well as develop therapeutic treatments for those with Vici syndrome.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes Induzidas Tipo de estudo: Prognostic_studies Limite: Child / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes Induzidas Tipo de estudo: Prognostic_studies Limite: Child / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article